Calcium channels as therapeutic targets in head and neck squamous cell carcinoma: current evidence and clinical trials
2024

Calcium Channels in Head and Neck Cancer

publication Evidence: moderate

Author Information

Author(s): Lin Jinye, Wang Xijia, Ma Shibo, Yang Dunhui, Li Kang, Li Dongcai, Zeng Xianhai

Primary Institution: Department of Otolaryngology, Longgang Otolaryngology hospital & Shenzhen Key Laboratory of Otolaryngology, Shenzhen Institute of Otolaryngology, Shenzhen, China

Hypothesis

Calcium signaling plays a crucial role in the progression of head and neck squamous cell carcinoma (HNSCC) and targeting calcium channels may provide therapeutic benefits.

Conclusion

Targeting calcium channels could be a promising strategy for developing new therapies for HNSCC.

Supporting Evidence

  • Calcium signaling is linked to cancer progression and drug resistance.
  • Calcium channels regulate processes like tumor proliferation and apoptosis evasion.
  • Targeting calcium channels may improve treatment outcomes for HNSCC.

Takeaway

This study looks at how calcium channels affect head and neck cancer and suggests that medicines targeting these channels might help treat the disease.

Methodology

This review examines existing literature on calcium channels and their role in HNSCC, along with current clinical trials targeting these channels.

Limitations

The review highlights the need for more specific studies on calcium signaling in HNSCC, as many existing studies focus on solid tumors in general.

Digital Object Identifier (DOI)

10.3389/fonc.2024.1516357

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication